Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 as a metadata update; no study data or core content is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision: v3.4.1 is displayed, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedGlossary display is added and new data fields such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted are shown, while corresponding Estimated fields are removed and the site revision is updated to v3.4.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.4 was added replacing v3.3.3, with no visible changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe list of study locations was updated to include many new sites across the US, Canada, Europe, Australia, and other regions, and several existing locations were removed.SummaryDifference2%

- Check89 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no changes to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.